Literature DB >> 23905558

Incidence of dementia: evidence for an effect modification by gender. The ILSA Study.

Marianna Noale1, Federica Limongi, Sabina Zambon, Gaetano Crepaldi, Stefania Maggi.   

Abstract

BACKGROUND: Gender differences for incidence of dementia among elderly people have been usually investigated considering gender as a predictor and not as a stratification variable.
METHODS: Analyses were based on data collected by the Italian Longitudinal Study on Aging (ILSA), which enrolled 5,632 participants aged 65-84 years between 1992 and 2000. During a median follow-up of 7.8 years, there were 194 cases of incident dementia in the participants with complete data. Cox proportional hazard models for competing risks, stratified by sex, were defined to determine risk factors in relation to developing dementia.
RESULTS: The incidence rate of dementia increased from 5.57/1,000 person-years at 65-69 years of age to 30.06/1,000 person-years at 80-84 years. Cox proportional hazard models for competing risks of incidence of dementia and death revealed that, among men, significant risk factors were heart failure, Parkinson's disease, family history of dementia, mild depressive symptomatology and age, while triglycerides were associated with a lower risk of developing dementia. Significant risk factors in women were age, both mild and severe depressive symptomatology, glycemia ≥109 mg/dL, and a BMI < 24.1 kg/m². Even as little as three years of schooling was found to be a significant protective factor against the incidence of dementia only for women.
CONCLUSIONS: Our results suggest that there is an effect modification by gender in our study population in relation to the association between low education level, lipid profile, BMI, and glycemia and dementia.

Entities:  

Mesh:

Year:  2013        PMID: 23905558     DOI: 10.1017/S1041610213001300

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

1.  Stroke and dementia risk: A systematic review and meta-analysis.

Authors:  Elżbieta Kuźma; Ilianna Lourida; Sarah F Moore; Deborah A Levine; Obioha C Ukoumunne; David J Llewellyn
Journal:  Alzheimers Dement       Date:  2018-08-31       Impact factor: 21.566

2.  Sex Differences in the Association Between Midlife Cardiovascular Conditions or Risk Factors With Midlife Cognitive Decline.

Authors:  Nan Huo; Prashanthi Vemuri; Jonathan Graff-Radford; Jeremy Syrjanen; Mary Machulda; David S Knopman; Clifford R Jack; Ronald Petersen; Michelle M Mielke
Journal:  Neurology       Date:  2022-01-05       Impact factor: 9.910

3.  Alzheimer's disease and related dementias and heart failure: A community study.

Authors:  Sheila M Manemann; David S Knopman; Jennifer St Sauver; Suzette J Bielinski; Alanna M Chamberlain; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  J Am Geriatr Soc       Date:  2022-03-18       Impact factor: 7.538

4.  Associations between coronary heart disease and risk of cognitive impairment: A meta-analysis.

Authors:  Xuan Liang; Yilin Huang; Xu Han
Journal:  Brain Behav       Date:  2021-03-20       Impact factor: 2.708

5.  A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets.

Authors:  Xiaohang Li; Qinying Wang; Tingting Hu; Ying Wang; Jian Zhao; Jing Lu; Gang Pei
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

Review 6.  Sex Differences in Cardiovascular Risk Factors for Dementia.

Authors:  Mi-Young Kim; Kyeongjin Kim; Chang Hyung Hong; Sang Yoon Lee; Yi-Sook Jung
Journal:  Biomol Ther (Seoul)       Date:  2018-11-01       Impact factor: 4.634

7.  Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study.

Authors:  Sara Ahmadi-Abhari; Maria Guzman-Castillo; Piotr Bandosz; Martin J Shipley; Graciela Muniz-Terrera; Archana Singh-Manoux; Mika Kivimäki; Andrew Steptoe; Simon Capewell; Martin O'Flaherty; Eric J Brunner
Journal:  BMJ       Date:  2017-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.